Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SITAGLIPTIN Cause Cerebrovascular accident? 478 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 478 reports of Cerebrovascular accident have been filed in association with SITAGLIPTIN (JANUVIA). This represents 2.4% of all adverse event reports for SITAGLIPTIN.

478
Reports of Cerebrovascular accident with SITAGLIPTIN
2.4%
of all SITAGLIPTIN reports
68
Deaths
364
Hospitalizations

How Dangerous Is Cerebrovascular accident From SITAGLIPTIN?

Of the 478 reports, 68 (14.2%) resulted in death, 364 (76.2%) required hospitalization, and 243 (50.8%) were considered life-threatening.

Is Cerebrovascular accident Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 478 reports have been filed with the FAERS database.

What Other Side Effects Does SITAGLIPTIN Cause?

Blood glucose increased (1,427) Pancreatic carcinoma (1,142) Product dose omission issue (1,125) Drug ineffective (1,057) No adverse event (994) Nausea (936) Pancreatitis (922) Diabetes mellitus inadequate control (744) Diarrhoea (712) Hypoglycaemia (674)

What Other Drugs Cause Cerebrovascular accident?

ROSIGLITAZONE (7,899) APIXABAN (7,237) RIVAROXABAN (4,111) ADALIMUMAB (2,756) LENALIDOMIDE (2,330) DABIGATRAN ETEXILATE (2,175) TESTOSTERONE (2,172) ASPIRIN (1,904) SACUBITRIL\VALSARTAN (1,864) INSULIN GLARGINE (1,805)

Which SITAGLIPTIN Alternatives Have Lower Cerebrovascular accident Risk?

SITAGLIPTIN vs SOAP SITAGLIPTIN vs SODIUM SITAGLIPTIN vs SODIUM BICARBONATE SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM SITAGLIPTIN vs SODIUM BORATE

Related Pages

SITAGLIPTIN Full Profile All Cerebrovascular accident Reports All Drugs Causing Cerebrovascular accident SITAGLIPTIN Demographics